ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis

Clinical trial NCT02126670 · COMPLETED

Trial details

NCT number: NCT02126670
Sponsor: Promius Pharma, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2014-04-01
Primary completion: 2014-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.